Trial Profile
Phase II clinical study of a liposome entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients with malignant pleural mesothelioma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs L NDDP (Primary)
- Indications Malignant-mesothelioma
- Focus Therapeutic Use
- 04 Oct 2005 New trial record.